{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:52:25Z","timestamp":1790610745373,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/mlr.0b013e31826c85d1","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T06:55:13Z","timestamp":1349765713000},"page":"920-927","source":"Crossref","is-referenced-by-count":3,"title":["The State of Disparities in Opportunistic Infection Prophylaxis for Blacks With HIV\/AIDS"],"prefix":"10.1097","volume":"50","author":[{"given":"Christine U.","family":"Oramasionwu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim M.","family":"Koeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene D.","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Frei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210211","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1086\/596756","article-title":"HIV-associated opportunistic infectionsgoing, going, but not gone: the continued need for prevention and treatment guidelines.","volume":"48","author":"Brooks","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R2-4-20210211","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/522759","article-title":"Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006.","volume":"45","author":"Keruly","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R4-4-20210211","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"R5-4-20210211","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R6-4-20210211","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-4-20210211","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/505147","article-title":"The survival benefits of AIDS treatment in the United States.","volume":"194","author":"Walensky","year":"2006","journal-title":"J Infect Dis"},{"key":"R8-4-20210211","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.259.8.1185","article-title":"Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS.","volume":"259","author":"Fischl","year":"1988","journal-title":"JAMA"},{"key":"R12-4-20210211","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/QAI.0b013e3181945f03","article-title":"HIV testing frequency among men who have sex with men attending sexually transmitted disease clinics: implications for HIV prevention and surveillance.","volume":"50","author":"Helms","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-4-20210211","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-138-8-200304150-00007","article-title":"Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4 cell strata.","volume":"138","author":"Palella","year":"2003","journal-title":"Ann Intern Med"},{"key":"R15-4-20210211","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1371\/journal.pmed.0040200","article-title":"Late HIV diagnosis: bad medicine and worse public health.","volume":"4","author":"Valdiserri","year":"2007","journal-title":"PLoS Med"},{"key":"R16-4-20210211","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/01.qai.0000243114.37035.de","article-title":"Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS.","volume":"43","author":"Schwarcz","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-4-20210211","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJMsa011565","article-title":"Participation in research and access to experimental treatments by HIV-infected patients.","volume":"346","author":"Gifford","year":"2002","journal-title":"N Engl J Med"},{"key":"R18-4-20210211","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.mcna.2005.03.005","article-title":"HIVAIDS: a minority health issue.","volume":"89","author":"Cargill","year":"2005","journal-title":"Med Clin North Am"},{"key":"R19-4-20210211","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00042560-199803010-00011","article-title":"Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS).","volume":"17","author":"Solomon","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R20-4-20210211","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/713613154","article-title":"Testing and treatment behaviour of HIV-infected women: white, African-American, Puerto Rican comparisons.","volume":"9","author":"Siegel","year":"1997","journal-title":"AIDS Care"},{"key":"R21-4-20210211","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00042560-199812010-00010","article-title":"Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.","volume":"19","author":"Sackoff","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R22-4-20210211","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.281.24.2305","article-title":"Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.","volume":"281","author":"Shapiro","year":"1999","journal-title":"JAMA"},{"key":"R23-4-20210211","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00042560-199812010-00005","article-title":"Factors associated with HIV-infected patients recognition and use of HIV medications.","volume":"19","author":"Jeffe","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R24-4-20210211","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1001\/jama.1991.03470190061030","article-title":"Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.","volume":"266","author":"Easterbrook","year":"1991","journal-title":"JAMA"},{"key":"R25-4-20210211","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM199403173301107","article-title":"Racial differences in the use of drug therapy for HIV disease in an urban community.","volume":"330","author":"Moore","year":"1994","journal-title":"N Engl J Med"},{"key":"R26-4-20210211","first-page":"123","article-title":"Access and use of medications in HIV disease.","volume":"34","author":"Smith","year":"1999","journal-title":"Health Serv Res"},{"key":"R27-4-20210211","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00126334-200112010-00006","article-title":"Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States.","volume":"28","author":"Asch","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-4-20210211","doi-asserted-by":"crossref","first-page":"III23","DOI":"10.1097\/01.mlr.0000175631.34438.1e","article-title":"High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States.","volume":"43","author":"Gebo","year":"2005","journal-title":"Med Care"},{"key":"R29-4-20210211","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00126334-200501010-00017","article-title":"Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.","volume":"38","author":"Gebo","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-4-20210211","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0027-9684(15)31110-X","article-title":"Disparities in antiretroviral prescribing for blacks and whites in the United States.","volume":"101","author":"Oramasionwu","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"R31-4-20210211","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2334-9-127","article-title":"Black race as a predictor of poor health outcomes among a national cohort of HIVAIDS patients admitted to US hospitals: a cohort study.","volume":"9","author":"Oramasionwu","year":"2009","journal-title":"BMC Infect Dis"},{"key":"R32-4-20210211","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0027-9684(15)31130-5","article-title":"HIVAIDS disparities: the mounting epidemic plaguing US Blacks.","volume":"101","author":"Oramasionwu","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"R33-4-20210211","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0027-9684(15)31133-0","article-title":"Evaluating HIVAIDS disparities for Blacks in the United States: a review of antiretroviral and mortality studies.","volume":"101","author":"Oramasionwu","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"R34-4-20210211","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/SMJ.0b013e318236c23a","article-title":"Differences in national antiretroviral prescribing patterns between Black and White HIVAIDS patients from 1996-2006: a cohort study.","volume":"104","author":"Oramasionwu","year":"2011","journal-title":"South Med J"},{"key":"R35-4-20210211","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/pds.2096","article-title":"Self-report of current and prior antiretroviral drug use in comparison to the medical record among HIV-infected patients receiving primary HIV care.","volume":"20","author":"Brouwer","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R36-4-20210211","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0895-4356(96)00141-2","article-title":"A comparison of patient interview data with pharmacy and medical records for patients with acquired immunodeficiency syndrome or human immunodeficiency virus infection.","volume":"49","author":"Law","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"R37-4-20210211","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/archinte.162.21.2458","article-title":"Distrust, race, and research.","volume":"162","author":"Corbie-Smith","year":"2002","journal-title":"Arch Intern Med"},{"key":"R38-4-20210211","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11606-009-0919-7","article-title":"Physician cultural competence and patient ratings of the patient-physician relationship.","volume":"24","author":"Paez","year":"2009","journal-title":"J Gen Intern Med"},{"key":"R39-4-20210211","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2105\/AJPH.2008.158949","article-title":"Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005.","volume":"100","author":"Lillie-Blanton","year":"2009","journal-title":"Am J Public Health"},{"key":"R41-4-20210211","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.1996.03540020068031","article-title":"Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.","volume":"276","author":"Carpenter","year":"1996","journal-title":"JAMA"}],"container-title":["Medical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MLR.0b013e31826c85d1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:18:09Z","timestamp":1620962289000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005650-201211000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mlr.0b013e31826c85d1","relation":{},"ISSN":["0025-7079"],"issn-type":[{"value":"0025-7079","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}